240 related articles for article (PubMed ID: 37835461)
1. Differentiation Syndrome in Acute Leukemia: APL and Beyond.
Woods AC; Norsworthy KJ
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835461
[TBL] [Abstract][Full Text] [Related]
2. Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment.
Rego EM; De Santis GC
Mediterr J Hematol Infect Dis; 2011; 3(1):e2011048. PubMed ID: 22110898
[TBL] [Abstract][Full Text] [Related]
3. Role of Prophylactic Steroids in Differentiation Syndrome.
Sultana J; Dutta J; Mustarin S; Dey P; Roy A; Mamoon MY
Cureus; 2022 Sep; 14(9):e29531. PubMed ID: 36312659
[TBL] [Abstract][Full Text] [Related]
4. The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome.
LaBella D; Regan S; Konig H; Egan DN; Bailey NA; Mawad R; Gilbert M; Pagel JM; Pu JJ
Front Oncol; 2022; 12():911745. PubMed ID: 35992790
[TBL] [Abstract][Full Text] [Related]
5. Differentiation syndrome in acute promyelocytic leukaemia.
Stahl M; Tallman MS
Br J Haematol; 2019 Oct; 187(2):157-162. PubMed ID: 31410848
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Differentiation Syndrome Associated with Treatment Regimens in Acute Myeloid Leukemia: A Systematic Review of the Literature.
Gasparovic L; Weiler S; Higi L; Burden AM
J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33081000
[TBL] [Abstract][Full Text] [Related]
7. The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.
de Almeida LY; Pereira-Martins DA; Weinhäuser I; Ortiz C; Cândido LA; Lange AP; De Abreu NF; Mendonza SES; de Deus Wagatsuma VM; Do Nascimento MC; Paiva HH; Alves-Paiva RM; Bonaldo CCOM; Nascimento DC; Alves-Filho JC; Scheucher PS; Lima ASG; Schuringa JJ; Ammantuna E; Ottone T; Noguera NI; Araujo CL; Rego EM
Front Oncol; 2021; 11():686445. PubMed ID: 34650910
[TBL] [Abstract][Full Text] [Related]
8. The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature.
Montesinos P; Sanz MA
Mediterr J Hematol Infect Dis; 2011; 3(1):e2011059. PubMed ID: 22220256
[TBL] [Abstract][Full Text] [Related]
9. [Acute kidney failure in differentiation syndrome: a possible complication during therapy with differentiating agents for acute promyelocytic leukemia. A case report].
Di Micco L; Mirenghi F; Morelli E; De Simone E
G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373469
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.
Yamamoto de Almeida L; Pereira-Martins DA; Lima ASG; Baggio MS; de Araujo Koury LC; Lange AP; Bassi SC; Scheucher PS; Rego EM
BMC Cancer; 2020 Aug; 20(1):821. PubMed ID: 32859169
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid syndrome.
Datta D; Gerardi DA
Conn Med; 2003 Oct; 67(9):541-3. PubMed ID: 14619342
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndrome.
Cardinale L; Asteggiano F; Moretti F; Torre F; Ulisciani S; Fava C; Rege-Cambrin G
World J Radiol; 2014 Aug; 6(8):583-8. PubMed ID: 25170395
[TBL] [Abstract][Full Text] [Related]
13. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
De Botton S; Dombret H; Sanz M; Miguel JS; Caillot D; Zittoun R; Gardembas M; Stamatoulas A; Condé E; Guerci A; Gardin C; Geiser K; Makhoul DC; Reman O; de la Serna J; Lefrere F; Chomienne C; Chastang C; Degos L; Fenaux P
Blood; 1998 Oct; 92(8):2712-8. PubMed ID: 9763554
[TBL] [Abstract][Full Text] [Related]
14. The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia.
Dore AI; Santana-Lemos BA; Coser VM; Santos FL; Dalmazzo LF; Lima AS; Jacomo RH; Elias J; Falcão RP; Pereira WV; Rego EM
J Leukoc Biol; 2007 Nov; 82(5):1340-3. PubMed ID: 17704297
[TBL] [Abstract][Full Text] [Related]
15. Differentiation syndrome and coagulation disorder - comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemia.
Luo JS; Zhang XL; Huang DP; Chen YQ; Wan WQ; Mai HR; Chen HQ; Wen H; Liu RY; Chen GH; Li Y; Luo XQ; Tang YL; Huang LB
Ann Hematol; 2023 Jul; 102(7):1713-1721. PubMed ID: 37199788
[TBL] [Abstract][Full Text] [Related]
16. Differentiation Syndrome with Severe Abdominal Pain During Induction Treatment of Acute Promyelocytic Leukemia: A Case Report.
Yan H; He D; Huang W; Chen F; He J; Cai Z; Zhao Y
J Pain Res; 2021; 14():1981-1984. PubMed ID: 34234544
[TBL] [Abstract][Full Text] [Related]
17. Do high-mobility group box 1 gene polymorphisms affect the incidence of differentiation syndrome in acute promyelocytic leukemia?
Hoseinzadeh G; Mohammadzadeh Z; Chahardouli B; Moghaddam KA; Mousavi SA; Omidkhoda A; Rostami S
Mol Biol Rep; 2022 Jul; 49(7):5997-6004. PubMed ID: 35526247
[TBL] [Abstract][Full Text] [Related]
18. Differentiation syndrome in patients with acute promyelocytic leukemia.
Rogers JE; Yang D
J Oncol Pharm Pract; 2012 Mar; 18(1):109-14. PubMed ID: 21364078
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure associated with the retinoic acid syndrome in acute promyelocytic leukemia.
Flombaum CD; Isaacs M; Reich L; Berman E; Warrell RP
Am J Kidney Dis; 1996 Jan; 27(1):134-7. PubMed ID: 8546128
[TBL] [Abstract][Full Text] [Related]
20. Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.
Guarnera L; Ottone T; Fabiani E; Divona M; Savi A; Travaglini S; Falconi G; Panetta P; Rapanotti MC; Voso MT
Front Oncol; 2022; 12():871590. PubMed ID: 35494081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
